Claudia Fraser
About Claudia Fraser
Claudia Fraser is a research scientist with a DPhil in Oncology from the University of Oxford, specializing in novel imaging agents for cancer research.
Claudia Fraser Research Scientist
Claudia Fraser is a research scientist with a strong background in oncology. Her career integrates extensive experience in both academic and industrial settings. Presently, she holds a DPhil in Oncology from the University of Oxford, where she conducted significant research in the field of developing novel fluorine-18 labelled PET imaging agents.
Claudia Fraser Education and Expertise in Oncology
Claudia Fraser earned her DPhil in Oncology from the University of Oxford. Her research primarily focused on the development of fluorine-18 labelled PET imaging agents designed to target proteins involved in the DNA damage response. This specialized knowledge in biochemistry and oncology positions her as an expert in her field, combining detailed medical research with practical applications in cancer imaging and diagnostics.
Project Experience of Claudia Fraser
Throughout her career, Claudia Fraser has worked on multiple projects intersecting the fields of chemistry and biology. Her experience includes industrial placements at prominent organizations such as Isomerase and AstraZeneca. These roles allowed her to expand her practical skills in drug discovery, biomedical research, and the application of advanced imaging techniques in oncology.
Claudia Fraser Research Focus
Claudia Fraser's research focus lies in the development of innovative imaging agents for cancer diagnostics. Specifically, her DPhil project at the University of Oxford concentrated on creating fluorine-18 labelled PET imaging agents that target proteins in the DNA damage response. This work aims to enhance the precision of cancer detection and treatment, providing significant contributions to the field of oncology.